Approval · Notice of Compliance 29878 · 2023
XERMELO: Notice of Compliance 29878
Issued January 11, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29878
- Date
- January 11, 2023
- Company
- Serb S.A.Brussels, Brussels Capital Region, Belgium
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XERMELO | 02481553 | Marketed |
Medicinal ingredients
- TELOTRISTAT ETIPRATE 250 MG per TAB